# X4 Pharmaceuticals, Inc: Form 8-K, filed Apr 24, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2025-04-24
- Accepted by EDGAR: Apr 24, 2025, 08:57 ET
- Period: 2025-04-24
- Accession: 0001628280-25-019507
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025019507/xfor-20250424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000162828025019507/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000162828025019507/xfor-20250424.htm

Filed Apr 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-019507. Last ingested by Listed: Oct 29, 2026, 10:01 ET. No prices; not investment advice.